Brian Daniel Webster - 03 Jun 2026 Form 4 Insider Report for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

Reporting relationship: President and Chief Executive Officer, Director
Issuer ticker: KMTS
Reported as of: 03 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Jun 2026, 18:35:29 UTC
Prior SEC filing: 18 May 2026
Next SEC filing: 17 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Brian Daniel Webster

Key filing fact

Brian Daniel Webster filed Form 4 for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) on 04 Jun 2026.

Key facts

This page summarizes Brian Daniel Webster's Form 4 filing for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Jun 2026, 18:35.

Change

Previous filing in this sequence was filed on 18 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001877188 Primary reporting owner

Webster Brian Daniel

Relationship: President and Chief Executive Officer, Director
Address: 3933 LAKE WASHINGTON BLVD NE, SUITE 200, KIRKLAND
Signature: /s/ Brian Daniel Webster
Signature date: 04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KMTS transaction

Common Shares

Award

Transaction value
Shares: +75,681
Change %: +23%
Price: $0.000000^*
Shares after: 410,467
Date: 03 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest over three years, with 1/3 vesting on each anniversary of June 3, 2026.

SEC remarks

President and Chief Executive Officer